Portal de Periódicos da CAPES

Endopeptidase 3.4.24.11 converts N -1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe- p -carboxyanilide into a potent inhibitor of angiotensin-converting enzyme

1993; Portland Press; Volume: 294; Issue: 3 Linguagem: Inglês

10.1042/bj2940681

1470-8728

C. H. Williams, Toshibumi Yamamoto, Dominic M. Walsh, David Allsop,

Coagulation, Bradykinin, Polyphosphates, and Angioedema

It was reported recently that N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide (CPP-A-A-F-pAB), an inhibitor of endopeptidase 3.4.24.15 (E-24.15), also inhibits angiotensin-converting enzyme (ACE) from rabbit lung. We have found that this compound is without effect on ACE purified from pig kidney, at a concentration some 1000-fold greater than the Ki reported for inhibition of the enzyme from lung. However, preincubation of CPP-A-A-F-pAB with neutral endopeptidase 3.4.24.11 (E-24.11) does result in potent inhibitory effects on ACE. We have shown this to be due to formation of a fragment, CPP-A-A, the structure of which is closely related to ACE inhibitors such as enalaprilat. CPP-A-A was found to be a potent inhibitor of pig ACE. Under the conditions used it had an IC50 value of 1.6 x 10(-8) M, compared with the value obtained for captopril of 7.5 x 10(-10) M. These results have important implications for studies of E-24.15 when using CPP-A-A-F-pAB in vivo or in crude tissue extracts where E-24.11 might also be present.